$IFRX宣布美国第2期ANCA相关性血管炎IXPLORE研究的Vilobelimab的阳性结果为$IFRX Announces Positive Topline Results for Vilobelimab from the U.S. Phase 2 ANCA-Associated Vasculitis IXPLORE Study
$IFRX宣布美国第2期ANCA相关性血管炎IXPLORE研究的Vilobelimab的阳性结果为$IFRX Announces Positive Topline Results for Vilobelimab from the U.S. Phase 2 ANCA-Associated Vasculitis IXPLORE Study
精彩评论